首页> 外文期刊>Journal of pediatric hematology/oncology: Official journal of the American Society of Pediatric Hematology/Oncology >The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
【24h】

The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.

机译:C反应蛋白,白细胞介素8和单核细胞趋化蛋白在高发性中性粒细胞减少性血液病患儿风险分层中的诊断价值。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND AIM: Recent advances in febrile neutropenia have highlighted the value of risk stratification especially that it can have important implications in terms of management. We aimed to identify a serum marker that may help to stratify febrile neutropenic pediatric patients treated for hematologic malignancies at the time of first evaluation. Thus, C-reactive protein (CRP), interleukin-8 (IL-8), and monocyte chemotactic protein-1-alpha (MCP-1-alpha) were evaluated for their predictive and diagnostic relevance in febrile episodes of cancer patients. PATIENTS AND METHODS: Within 24 hours of fever, CRP, IL-8, and MCP-1 serum levels were measured and the levels of these markers were related to the clinical findings of the patients. For this purpose, we collected and analyzed clinical data of 85 fever episodes occurring in 76 patients with hematologic malignancies, presenting to the Department of Pediatric Oncology, National Cancer Institute, Cairo University, during a 6-month period. RESULTS: Neutropenic children with febrile episodes were classified into 2 groups, a group with unexplainable fever (group I, n=26) and another group with either blood culture positive, and/or fever periods with a documented clinical sepsis and/or local infection (group II, n=59). Clinically, local sites of infection were encountered in 39 cases (45.9%), whereas a positive blood culture was detected in 20 cases. CRP, IL-8, and MCP-1 levels were significantly lower in group I versus group II (P value <0.001). There were overlaps of values between groups. CRP > or =90 mg/L was significantly associated with chemotherapy-related neutropenia and fever owing to bacteremia (P=0.038). The sensitivity, specificity, negative and positive predictive values of CRP, MCP-1, and IL-8 were (70%, 73%, 51%, and 85%), (64%, 92%, 53%, and 95%), and (71%, 77%, 54%, and 88%), respectively. Combining 2 or 3 markers improved the diagnostic performance of these test, as 78% of group II had elevated 2 or 3 markers versus 16% of the group with no evident infection. CONCLUSIONS: Low levels of CRP, MCP-1, and IL-8 could identify patients with unexplainable fever; whereas, high levels of these markers were of help in the diagnosis of infectious episodes. A model combining more than 1 marker is recommended in the assessment of febrile neutropenia.
机译:背景与目的:高热性中性粒细胞减少症的最新进展突出了风险分层的价值,特别是它在管理方面可能具有重要意义。我们的目的是在首次评估时确定一种血清标志物,该标志物可能有助于对因血液系统恶性肿瘤治疗的发热性中性粒细胞减少症小儿患者进行分层。因此,评估了C反应蛋白(CRP),白细胞介素8(IL-8)和单核细胞趋化蛋白-1-α(MCP-1-alpha)在癌症患者高热发作中的预测和诊断意义。患者和方法:在发烧的24小时内,测量了CRP,IL-8和MCP-1的血清水平,这些标志物的水平与患者的临床表现有关。为此,我们收集并分析了在76个月内发生于76个血液系统恶性肿瘤中的85例发烧发作的临床数据,并在6个月内向开罗大学国家癌症研究所小儿肿瘤科呈报。结果:中性粒细胞减少的高热发作儿童分为两组,一组出现无法解释的发热(第一组,n = 26),另一组血液培养呈阳性,和/或出现发热期,并有临床败血症和/或局部感染的记录(第二组,n = 59)。临床上,在39例(45.9%)中遇到了局部感染部位,而在20例中检测到阳性血培养。 I组的CRP,IL-8和MCP-1水平显着低于II组(P值<0.001)。组之间的价值观存在重叠。 CRP>或= 90 mg / L与因菌血症引起的化疗相关的中性粒细胞减少和发烧显着相关(P = 0.038)。 CRP,MCP-1和IL-8的敏感性,特异性,阴性和阳性预测值分别为(70%,73%,51%和85%),(64%,92%,53%和95%) )和(分别为71%,77%,54%和88%)。组合2或3个标记物可改善这些测试的诊断性能,因为II组的78%具有2或3个标记物升高,而没有明显感染的组为16%。结论:低水平的CRP,MCP-1和IL-8可以鉴别出无法解释的发热患者。而这些标记物的高水平有助于诊断感染性发作。建议在发热性中性粒细胞减少症的评估中结合使用一种以上标记的模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号